![Steven Albers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Albers
Public Communications Contact chez
FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Profil
Mr. Steven Albers is an Executive Vice President-Public Affairs at NewAmsterdam Pharma Co. NV and a Partner at 365 Capital Management BV.
Postes actifs de Steven Albers
| Sociétés | Poste | Début |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Public Communications Contact | 01/01/2026 |
365 Capital Management BV
 365 Capital Management BV Investment ManagersFinance 365 Capital invests in mid-market companies located in Netherlands with EBITDA of EUR 4 million. The firm focuses on companies operating across a broad range of sectors and industries. It participates in buyout transactions with an investment size of EUR 15- 40 million. | Fondateur | 01/09/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
365 Capital Management BV
365 Capital Management BV Investment ManagersFinance 365 Capital invests in mid-market companies located in Netherlands with EBITDA of EUR 4 million. The firm focuses on companies operating across a broad range of sectors and industries. It participates in buyout transactions with an investment size of EUR 15- 40 million. | Finance |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
